Midday movers: Krispy Kreme, Tesla, and Reddit rise

Reddit (RDDT) stock continues to slide as short-sellers eye stock

Shares of Reddit (NYSE: RDDT) are down for the second day in a row as short-sellers reportedly target the stock.

The company's strong debut, which saw its shares jump significantly, is said to have drawn substantial bearish bets against the social... More

Tesla (TSLA) and CATL: can this battery ‘power couple’ re-charge the US EV market? - Morgan Stanley

A recent Bloomberg report stated that CATL is working with Tesla (NASDAQ: TSLA) on a fast-charging battery in Nevada. In a note this week, analysts at Morgan Stanley assessed whether the link-up can recharge the US electric vehicle (EV) market.

The report regarding CATL and Tesla comes after news that CATL is supplying machinery to Tesla's Giga Nevada, deepening the collaborative... More

HSBC starts Spotify (SPOT) at buy, cites significant opportunities

Spotify (NYSE: SPOT) stock was initiated with a Buy rating and $310 price target at HSBC on Wednesday. Shares of the company are up more than 1% premarket.

In a research note, the bank told investors that Spotify is a music streaming leader with new... More

Trump Media & Technology Group (DJT) shares jump premarket

After a more than 16% gain on its market debut, shares of Trump Media & Technology Group (NASDAQ: DJT) are up a further 16% premarket.

In fact, on Tuesday, Donald Trump's social media company jumped more than 50% only minutes after it began public... More

Tesla (TSLA) seeks to expand ‘full self-driving’ software use - WSJ

According to a report by The Wall Street Journal on Tuesday, Tesla (NASDAQ: TSLA) is ramping up the promotion of its Full Self-Driving (FSD) capability as it looks to expand its use of the feature to increase revenue as it faces the possibility of reduced... More

Viking Therapeutic (VKTX) PT Raised to $125 at BTIG

BTIG analyst Justin Zelin raised the price target on Viking Therapeutic (NASDAQ: VKTX) to $125.00 (from $100.00) while maintaining a Buy rating.

The analyst commented, "Viking is up +~25% (vs +0.75% XBI) this morning following presentation of impressive first in human data for oral VK2735, demonstrating 3.3% pbo adj weight loss in the highest dose cohort (40mg QD, n=7) at 28-days with an... More